Cargando…

SARS-CoV-2 Antibody Profile of Immune Globulin Preparations

Detalles Bibliográficos
Autores principales:	Park, Hyun, Gada, Satyen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Mosby, Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804455/ http://dx.doi.org/10.1016/j.jaci.2021.12.241

Ejemplares similares

SARS-COV-2 ANTIBODY LEVELS CONTINUE TO RISE IN IMMUNE GLOBULIN PREPARATIONS
por: Wang, Q., et al.
Publicado: (2022)

Antithymocyte-globulin: Worsening of SARS-CoV-2 infection: case report
Publicado: (2020)

Profile of specific antibodies to the SARS-CoV-2
por: Mou, Danlei, et al.
Publicado: (2021)

Antihuman globulin test reactivity in SARS-CoV-2 infection-positive patients
por: Thakkar, Sheenam, et al.
Publicado: (2022)

Production of anti‐SARS‐CoV‐2 hyperimmune globulin from convalescent plasma
por: Vandeberg, Peter, et al.
Publicado: (2021)

Potent Anti‐SARS‐CoV‐2 Efficacy of COVID‐19 Hyperimmune Globulin from Vaccine‐Immunized Plasma
por: Yu, Ding, et al.
Publicado: (2022)

Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement
por: Zang, Jinkai, et al.
Publicado: (2020)

Antibody-mediated immunity to SARS-CoV-2 spike
por: Errico, John M., et al.
Publicado: (2022)

Profile of specific antibodies to SARS-CoV-2: The first report
por: Xiao, Ai Tang, et al.
Publicado: (2020)

Immune Profile of SARS-CoV-2 Variants of Concern
por: La Porta, Caterina A. M., et al.
Publicado: (2021)

Immune-globulin/methylprednisolone/tocilizumab: Lack of response following off-label use in SARS-CoV-2 infection: case report
Publicado: (2021)

GMP Manufacturing and IND-Enabling Studies of a Recombinant Hyperimmune Globulin Targeting SARS-CoV-2
por: Mizrahi, Rena A., et al.
Publicado: (2022)

Antibody Response to SARS CoV-2 Immunization in Patients with Immunodeficiency
por: DiGiacomo, Daniel, et al.
Publicado: (2022)

Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization
por: Klasse, PJ, et al.
Publicado: (2020)

Immune evasion of neutralizing antibodies by SARS-CoV-2 Omicron
por: Wang, Lidong, et al.
Publicado: (2023)

Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions
por: Gavor, Edem, et al.
Publicado: (2020)

Profile of SARS-CoV-2
por: Heinz, Franz X., et al.
Publicado: (2020)

Antibody profile in post-vaccinated & SARS-CoV-2 infected individuals
por: Patil, Rucha, et al.
Publicado: (2022)

Re: Profile of specific antibodies to SARS-CoV-2: The first report
por: Zeng, Zhikun, et al.
Publicado: (2020)

SARS-CoV-2 and enhancing antibodies
por: Denner, Joachim
Publicado: (2020)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

Cross-Reactivity of Antibodies in Intravenous Immunoglobulin Preparation for Protection against SARS-CoV-2
por: Osaka, Toshifumi, et al.
Publicado: (2023)

Competitive Immunoassay of SARS-CoV-2 Using Pig Sera-Derived Anti-SARS-CoV-2 Antibodies
por: Bong, Ji-Hong, et al.
Publicado: (2021)

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
por: Bates, Timothy A., et al.
Publicado: (2020)

Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections
por: Lv, Huibin, et al.
Publicado: (2020)

Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
por: Lv, Huibin, et al.
Publicado: (2020)

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
por: Bates, Timothy A., et al.
Publicado: (2021)

Absence of SARS‐CoV‐2 RNA and anti‐SARS‐CoV‐2 antibodies in stray cats
por: Stranieri, Angelica, et al.
Publicado: (2021)

Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with an endemic human CoV
por: Ladner, Jason T, et al.
Publicado: (2020)

The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies
por: Molaei, Soheila, et al.
Publicado: (2021)

Evaluation of Antibody-Dependent Enhancement of SARS-CoV Infection in Rhesus Macaques Immunized with an Inactivated SARS-CoV Vaccine
por: Luo, Fan, et al.
Publicado: (2018)

Antibody profiling and prevalence in US patients during the SARS-CoV2 pandemic
por: Krishnamurthy, Hari Krishnan, et al.
Publicado: (2020)

Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infections
por: Selva, Kevin J., et al.
Publicado: (2023)

Seven-Month Analysis of Five SARS-CoV-2 Antibody Assay Results after ChAdOx1 nCoV-19 Vaccination: Significant Decrease in SARS-CoV-2 Antibody Titer
por: Jeong, Seri, et al.
Publicado: (2021)

Preparation, Purification and Performance Evaluation of Polyclonal Antibody Against SARS-CoV-2 Produced in Rat
por: Yaghoobizadeh, Fatemeh, et al.
Publicado: (2023)

Profiles of host immune impairment in Plasmodium and SARS-CoV-2 infections
por: Chaturvedi, Rini, et al.
Publicado: (2022)

SARS CoV-2 genetic jump to a new SARS CoV-3 pandemic: Let’s be prepared
por: Kelleni, Mina T.
Publicado: (2023)

Immune Responses in SARS-CoV-2, SARS-CoV, and MERS-CoV Infections: A Comparative Review
por: Irani, Soussan
Publicado: (2022)

Antibody-mediated neutralization of SARS-CoV-2
por: Gruell, Henning, et al.
Publicado: (2022)

Neutralizing antibodies for SARS-CoV-2 infection
por: Berenguer, Juan
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_56be5edgokfovmf59uqslnri2v